AI assistant
Morepen Laboratories Ltd. — Capital/Financing Update 2024
Aug 5, 2024
59389_rns_2024-08-05_d871102d-0be4-4364-85e0-ccd5a8478962.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [92 x 841] intentionally omitted <==
==> picture [77 x 75] intentionally omitted <==
==> picture [159 x 37] intentionally omitted <==
Date: August 05, 2024
| The National Stock Exchange of India Limited | BSE Limited |
|---|---|
| Listing Department | Department of Corporate Services |
| Exchange Plaza, Bandra Kurla Complex | Floor 25, Phiroze Jeejeebhoy Towers |
| Bandra (East) | Dalal Street |
| Mumbai 400 051 | Mumbai 400 001 |
| Symbol: MOREPENLAB | Security code no.: 500288 |
-
Sub: Disclosure of the details of allotment in the Issue (as defined hereinafter) by Morepen Laboratories Limited (the “Company”) in accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements), 2015, as amended (the “SEBI Listing Regulations”
-
Re: Qualified institutions placement of equity shares of face value ₹2 each (the “Equity Shares”) by Morepen Laboratories Limited (the “Company”) under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), and Sections 42 and 62(1)(c) of the Companies Act, 2013, as amended, including the rules made thereunder (the “Issue”).
Dear Sir/ Madam,
In continuation of our earlier intimation dated August 1, 2024, and August 5, 2024, with respect to the Issue which opened on August 1, 2024, and closed on August 5, 2024, please note that the QIP Committee of the Board of Directors of the Company (“ Committee ”) has, at its meeting held today i.e., August 5, 2024, approved the issue and allotment of 3,67,84,991 Equity Shares of face value ₹2 each to eligible qualified institutional buyers at the Issue price of ₹ 54.37 per Equity Share (including a premium of ₹ 52.37 per Equity Share) and reflecting a discount of ₹ 2.86 (i.e. 5%) on the floor price of ₹ 57.23] aggregating to ₹ 20,000 Lakhs pursuant to the Issue in accordance with provisions of SEBI ICDR Regulations.
The Issue opened on August 1, 2024, and closed on August 5, 2024, and the same was intimated to you through our letters dated August 1, 2024, and August 5, 2024, respectively .
Further, we have enclosed herewith the list of allottees who have been allotted more than five percent (5%) of the Equity Shares offered in the Issue, marked as Annexure A . The shareholding pattern of the Company, before and after the Issue, will be submitted along with the listing application in the format specified in Regulation 31 of the SEBI Listing Regulations, as amended.
Pursuant to the allotment of Equity Shares in the Issue, the paid-up equity share capital of the Company will stand increased from ₹10222.71 Lakh comprising of 51,11,68,708 Equity Shares to ₹ 10958.41 Lakh, comprising of 54,79,53,699 Equity Shares of ₹2 each.
Morepen Laboratories Limited
CIN NO. L24231 HP1984PLC006028
Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com
Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]
==> picture [92 x 841] intentionally omitted <==
==> picture [77 x 75] intentionally omitted <==
==> picture [159 x 37] intentionally omitted <==
The meeting of the Committee commenced at 9.35 p.m. and concluded at 10.00 p.m., today.
The information as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations Disclosure Requirements) Regulations, 2015, as amended, (" SEBI Listing Regulations ") read with Schedule - III part- A to the SEBI Listing Regulations and SEBI circular SEBI/HO/CFD/PoD2/CIR/P/2023/120 and SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 11, 2023, and July 13, 2023, respectively, is as follows:
| Type of securities issued | Equity Shares |
|---|---|
| Type of issuance | Qualified Institutions Placement |
| Total no. of securities issued | 3,67,84,991 Equity Shares of face value of ₹2 each at an issue price of ₹54.37 per Equity Share (including a premium of ₹52.37 per Equity Share) |
| Total amount for which securities issued |
₹ 20,000 Lakhs |
We request you to take the above on record and the treat the same as compliance under the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended .
Thanking you,
Yours faithfully,
For Morepen Laboratories Limited
Vipul Digitally signed by Vipul Kumar Kumar Srivastava Srivastava Date: 2024.08.05 22:09:53 +05'30' Vipul Kumar Srivastava Company Secretary F-12148
Morepen Laboratories Limited
CIN NO. L24231 HP1984PLC006028
Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com
Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]
==> picture [92 x 841] intentionally omitted <==
==> picture [77 x 75] intentionally omitted <==
==> picture [159 x 37] intentionally omitted <==
ANNEXURE A
LIST OF ALLOTTEES WHO HAVE BEEN ALLOTTED MORE THAN 5% OF THE EQUITY SHARES OFFERED IN THE ISSUE
| S. No. | Name of the Allottees | Category | No. of Equity Shares Allotted |
% of Total Issue Size |
|---|---|---|---|---|
| 1. | BOFA Securities Europe SA - ODI |
FPI | 82,76,623 | 22.50 |
| 2. | Neomile Growth Fund Series 1 | AIF | 55,17,748 | 15.00 |
| 3. | Citigroup Global Markets Mauritius Private Limited |
FPI | 42,94,647 | 11.67 |
| 4. | Societe Generale - ODI | FPI | 41,75,103 | 11.35 |
| 5. | Samsung India Securities Master Investment Trust Equity |
FPI | 35,82,014 | 9.74 |
| 6. | Samsung India Small and Mid Cap Focus Securities Master Inv Trust Equity |
FPI | 24,87,509 | 6.76 |
Morepen Laboratories Limited
CIN NO. L24231 HP1984PLC006028
Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com
Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]